Q&A: Vaccine Researcher David Diemert, MD

August 31, 2021

The Delta variant of the SARS-CoV-2 virus is causing a surge in COVID-19 cases globally, including in the United States, where there has been a sharp increase in reported cases. The Clinical Director of the GW Vaccine Research Unit, Dr. David Diemer, discusses the Delta Variant and the Fourth Wave of the COVID-19 Pandemic. Take a look at this article to see what Dr. Diemert has to say 

Latest News

August 31, 2023
George Washington's Vaccine Research Unit is participating in the Project NextGen clinical study. Read this article on the journey to preparing the vaccines and treatments for the next outbreak.
April 20, 2023
Read more information about how The George Washington Vaccine Research Unit is looking for adolescents between the ages of 12 and 17 to participate in a Mpox vaccine trial. The need for adolescents is vital for researchers to get an approved vaccine for adolescents to prevent another outbreak.
December 8, 2022
Read more about the new hope found in Phase 1 clinical trials for the HIV vaccine.